110 related articles for article (PubMed ID: 5040921)
1. [Photographic control of the evolution of diabetic retinopathy (hemorrhagic component) during a medical treatment].
Bruni B; Della Valle A
Minerva Med; 1972 Jun; 63(48):2671-89. PubMed ID: 5040921
[No Abstract] [Full Text] [Related]
2. [Action of Dicynone 500 in different hemorrhagic retinopathies].
Bregeat P; Regnault F
Arch Ophtalmol Rev Gen Ophtalmol; 1972 Jan; 32(1):59-62. PubMed ID: 4261211
[No Abstract] [Full Text] [Related]
3. [The action of calcium dobesilate in diabetic retinopathy].
Sevin R; Cuendet JF
Bull Mem Soc Fr Ophtalmol; 1969; 82():170-80. PubMed ID: 5402400
[No Abstract] [Full Text] [Related]
4. [Action of synthetic derivatives of Congo red. Angiographic study].
Zenatti C
Ann Ocul (Paris); 1971 Mar; 204(3):257-70. PubMed ID: 5089202
[No Abstract] [Full Text] [Related]
5. [Calcium dobesilate in diabetic retinopathy].
Wirtel J
Rev Med Liege; 1974 Sep; 29(17):513-5. PubMed ID: 4428113
[No Abstract] [Full Text] [Related]
6. [Diabetic retrohialoidian hemorrage--invasive minimal treatment].
Buliga S; Toma C; Taina A; Beraru V; Benone C
Oftalmologia; 2011; 55(4):82-5. PubMed ID: 22642141
[TBL] [Abstract][Full Text] [Related]
7. [Lekozim in the treatment of the vitreoretinal traction syndrome in proliferative diabetic retinopathy].
Polunin GS; Glukhoded SV; Pirogova EP
Vestn Oftalmol; 1987; 103(4):41-4. PubMed ID: 3672705
[No Abstract] [Full Text] [Related]
8. [Naftidrofuryl in the treatment of simple diabetic retinopathy. A double-blind study].
Klein M; Hirche H
Klin Monbl Augenheilkd; 1985 Sep; 187(3):195-201. PubMed ID: 3906248
[TBL] [Abstract][Full Text] [Related]
9. [Use of conjugated estrogens in diabetic retinopathy].
Németh L
Klin Monbl Augenheilkd; 1969 Oct; 155(4):543-8. PubMed ID: 4315571
[No Abstract] [Full Text] [Related]
10. [Calcium dobesilate action in ophthalmology].
Offret G; Guyot C
Arch Ophtalmol Rev Gen Ophtalmol; 1972 Mar; 32(3):241-4. PubMed ID: 4263267
[No Abstract] [Full Text] [Related]
11. [Diagnostic and prognostic importance of vascular fragility. Its present treatment].
Plauchu M; Molinie C; Savoye B; Arnaud P
Lyon Med; 1966 Nov; 216(48):1285-90. PubMed ID: 5987777
[No Abstract] [Full Text] [Related]
12. [Treatment of diabetic retinopathy and recurrent hemorrhages into the vitreous with calcium dobesilate].
Favre M
Ophthalmologica; 1970; 161(4):389-93. PubMed ID: 5483904
[No Abstract] [Full Text] [Related]
13. [Etamsylate therapy in hemorrhagic diathesis. Clinical experimental studies on the effect of altodor].
Ruhl E; Kümper H
Munch Med Wochenschr; 1971 Nov; 113(47):1601-4. PubMed ID: 5171666
[No Abstract] [Full Text] [Related]
14. [Reduction of surgical bleeding by a synthetic product: D.B.S.D. Its value in general surgery].
Estour ME
Lyon Med; 1968 Apr; 219(17):1439-40 passim. PubMed ID: 5760838
[No Abstract] [Full Text] [Related]
15. [Pyridinolcarbamate (anginin) in the treatment of diabetic angiopathies].
Tirkina TN; Aleksandrova LM; Kliachko VR; Mazovetskiĭ AG
Ter Arkh; 1974; 46(1):107-10. PubMed ID: 4453966
[No Abstract] [Full Text] [Related]
16. [Prevention of capillary hemorrhage in general and gynecological surgery].
Jacobelli G; Pozzi M
Minerva Med; 1969 Nov; 60(93):4615-9. PubMed ID: 5357303
[No Abstract] [Full Text] [Related]
17. Quantitative analysis of retinopathy in type 2 diabetes: identification of prognostic parameters for developing visual loss secondary to diabetic maculopathy.
Hove MN; Kristensen JK; Lauritzen T; Bek T
Acta Ophthalmol Scand; 2004 Dec; 82(6):679-85. PubMed ID: 15606463
[TBL] [Abstract][Full Text] [Related]
18. [Decrease of vascular fragility in diabetic retinopathy through calciumdobesilate (author's transl)].
Freyler H; Sehorst W
Klin Monbl Augenheilkd; 1974 Feb; 164(2):246-51. PubMed ID: 4842139
[No Abstract] [Full Text] [Related]
19. Effect of ruboxistaurin on visual loss in patients with diabetic retinopathy.
; Aiello LP; Davis MD; Girach A; Kles KA; Milton RC; Sheetz MJ; Vignati L; Zhi XE
Ophthalmology; 2006 Dec; 113(12):2221-30. PubMed ID: 16989901
[TBL] [Abstract][Full Text] [Related]
20. [Value of tetrahydroxy flavan-diol in ophthalmology, especially in chronic retinopathy (40 cases)].
Magnard G; Franck JP; Dorne PA
Lyon Med; 1970 Jan; 223(4):259-63. PubMed ID: 5435320
[No Abstract] [Full Text] [Related]
[Next] [New Search]
